[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.238.168. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 73
Citations 0
In This Issue of JAMA Otolaryngology
March 2015

Highlights

JAMA Otolaryngol Head Neck Surg. 2015;141(3):199. doi:10.1001/jamaoto.2014.2142

Torre and associates investigated the impact of human immunodeficiency virus–seropositivity (HIV+) on hearing loss with age and the effect of antiretroviral therapy. Pure-tone air conduction thresholds were collected from 250 to 8000 Hz for 262 men, 117 HIV+, and 134 women, 105 HIV+, from the Multicenter Aids Cohort Study and the Women’s Interagency HIV Study. They found that high-frequency and low-frequency pure-tone averages in the better ear were significantly higher for HIV+ participants than HIV-seronegative participants, revealing significantly poorer hearing in the HIV+ adults. The reduced hearing in the lower frequencies may lead to increased communication problems in this group.

First Page Preview View Large
First page PDF preview
First page PDF preview
×